Salvage therapy with etoposide and mitoxantrone in patients with refractory acute myeloid leukemia: a retrospective cohort study.

Ann Med Surg (Lond) · 2026 · PMC12767975 · PMID 41497074

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the current study, patients who responded to EM but did not undergo HSCT showed a trend towards improved survival with HIDAC consolidation compared to other regimens or no consolidation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.